Form D Explorer

Inspect source fieldsReport a record issue

Form D — D&D Pharmatech Inc.

0002077939-25-000001 · filed Aug 1, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$10,800,000
Reported amount sold
$10,800,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
D&D Pharmatech Inc.
CIK
2077939
Entity
Corporation
Jurisdiction
KOREA, REPUBLIC OF
Year incorporated
—
Address
4TH FLOOR, 27, GEUMTO-RO 80BEON-GIL
SEONGNAM-SI, Korea, Republic Of 13454
Phone
82-31-8019-7771

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗